ArticleFrontiers in clinical diabetes and healthcare2024
Inhibition of leukotrienes and their potential role in type 1 diabetes pathogenesis: implications for montelukast as a therapeutic agent: a case report.
Pavel Fatulla et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.